Olympus, a medical supply company based in Pennsylvania, warned customers that its High Flow Insufflation Unit may suddenly over-inflate air into a patient’s body without a warning. One death and 10 serious injuries have been reported to the FDA.
Freeman Health System is adding two 24-foot-long box trailers equipped for mass casualties to its three-hospital system, The Joplin Globe Globe reported.
The leading tactics to combat supply chain disruptions are confirming vendor-approved product alternatives and stockpiling, according to a Kaufman Hall report published Oct. 24.
The CDC is urging clinicians to prioritize 100 milligram doses of a new respiratory syncytial virus drug for infants at highest risk of severe disease amid limited supply.
Demand for the first FDA-approved respiratory syncytial virus drug for children is surpassing what the drugmaker expected, and the CDC has paused orders.